XML 37 R26.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of stock option activity under all of the Company's equity incentive plans

    

    

    

    

Weighted

    

Weighted

Average

Shares

Number of

Average

Remaining

Aggregate

Available for

Shares

Exercise

Contractual

Intrinsic

Grant

Outstanding

Price

Life (Years)

Value (000’s)

Available and outstanding as of December 31, 2024

92,020

296,391

$

50.50

7.97

$

26

2022 Equity incentive plan increase

220,106

Granted

 

(45,090)

 

45,090

 

4.89

 

 

Forfeited

 

21,988

 

(21,988)

 

112.14

 

 

Available and outstanding as of September 30, 2025

289,024

319,493

$

38.12

7.54

$

40

Vested and exercisable as of September 30, 2025

 

182,079

$

51.15

 

6.51

$

 

Schedule of assumptions utilized for option grants

    

Three Months Ended

    

Nine Months Ended

September 30, 

September 30, 

2025

    

2024

 

2025

    

2024

 

Risk-free interest rate

 

3.82

%  

4.20

%

 

3.86

%  

4.20

%

Expected dividend yield

 

%  

%

 

%  

%

Expected volatility

52.36

%  

54.30

%

 

52.99

%  

54.35

%

Expected term (in years)

 

6.1

 

5.8

 

6.1

 

5.7

 

Schedule of stock-based compensation expense recognized in the Company's consolidated statements of operations

    

Three Months Ended

    

Nine Months Ended

September 30, 

September 30, 

2025

    

2024

2025

    

2024

Cost of revenue, net

$

39

$

75

$

125

$

140

Research and development

 

104

 

146

 

367

 

414

Sales and marketing

 

22

 

24

 

65

 

104

General and administrative

 

211

 

479

 

626

 

669

Total

$

376

$

724

$

1,183

$

1,327